What are the options in HER2 postive breast cancer treatments are we moving to t-DXd in first line?
Hassan GHAZAL
oncologist, Dubai
oncologist, Dubai
New User? Click here to register
Text generated by AI based on an exclusive interview, revised and reviewed by
Yazid BELKACEMI
Chairman of the Radiation Oncology Department and the Henri-Mondor Breast Center, Henri- Mondor University Hospital, Créteil, France
Yazid BELKACEMI
Oncologue-Radiothérapeute, Créteil, France
Dana Haddad
MD, PhD, American Board Certified consultant breast radiologist
and Head of Breast Imaging at Healthbay Polyclinic in Dubai, UAE
Copyright © 2025 - BCU